Isis Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | 212.0 | 36.1 | (53.2) |
| Net Investing Cash Flow | (234.2) | (55.6) | (32.6) |
| Net Financing Cash Flow | 107.6 | 43.7 | 149.5 |
| Net Change in Cash | 85.4 | 24.1 | 63.6 |
| Depreciation & Amortization | 6.8 | 5.2 | 5.5 |
| Capital Expenditures | (13.7) | (2.3) | (1.0) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
